The Astria team has extensive rare disease development and commercialization experience coupled with an unrelenting passion to deliver impactful therapeutics to patients.
We are backed by leading life science investors and have raised significant capital.
We are actively looking to in-license therapeutics across a range of development stages with a potential to address unmet needs in rare and niche allergic and immunological disease.
Please send any inquiries by email to:
BD@astriatx.com
